Nanoimaging and neurological surgery

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 2, Issue 6, 2010, Pages 601-617

  Grosu, Ion Dan ^a   Toms, Madalina Alexandra ^a   Toms, Steven A ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROMAGNETIC SPECTRA; IMAGE GUIDANCES; IMAGING MODALITY; NANO-IMAGING; NANOPARTICULATES; OPERATING ROOM ENVIRONMENT; SURGICAL INTERVENTIONS; SURGICAL PROCEDURES;

IONIZING RADIATION; MAGNETIC RESONANCE; ULTRASONIC IMAGING; ULTRASONOGRAPHY;

SURGERY;

AMINOLEVULINIC ACID; ANTIGEN; ANTINEOPLASTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; CARBON NANOTUBE; CONTRAST MEDIUM; DENDRIMER; FLUORESCENT DYE; FLUOROCARBON; GADOLINIUM; GADOLINIUM PENTETATE; GOLD NANOPARTICLE; LIPOSOME; MACROGOL; MAGNETIC NANOPARTICLE; NANOMATERIAL; NANOPARTICLE; NANOSHELL; PARAMAGNETIC NANOPARTICLE; QUANTUM DOT; RADIOISOTOPE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER SURGERY; COMPUTER ASSISTED SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DIFFUSE REFLECTANCE SPECTROSCOPY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; ECHOGRAPHY; FLUORESCENCE SPECTROSCOPY; GENE THERAPY; GLIOBLASTOMA; GLIOMA; HUMAN; IMAGE GUIDED SURGERY; IMAGE RECONSTRUCTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; INTRAOPERATIVE PERIOD; IONIZING RADIATION; LIPID BILAYER; LIPOSOMAL DELIVERY; NANOIMAGING; NEUROIMAGING; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATING ROOM; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL SPECTROSCOPY; PARTICLE SIZE; PEROPERATIVE ECHOGRAPHY; PHOTOACOUSTIC SPECTROSCOPY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REPEATED DRUG DOSE; REVIEW; SCINTILLATION CAMERA; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY; SIGNAL NOISE RATIO; SPECTROSCOPY; STEREOTACTIC RADIOSURGERY; TRANSMISSION SPECTROSCOPY; TUMOR LOCALIZATION; X RAY FILM; ANIMAL; METHODOLOGY; MOLECULAR IMAGING; MOUSE; NANOTECHNOLOGY; RAT; ULTRASTRUCTURE;

ANIMALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; HUMANS; MICE; MOLECULAR IMAGING; NANOSTRUCTURES; NANOTECHNOLOGY; NEUROSURGERY; RATS; SURGERY, COMPUTER-ASSISTED;

EID: 79952201461     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.106     Document Type: Review

References (143)

1. Hunt MA, Bago AG, Neuwelt EA. Single dose contrast agent for intraoperative MR imaging of intrinsic brain tumors by using ferumoxtran-10. AJNR Am J Neuroradiol 2005, 26:1084-1088.
2. Gneveckow U, Jordan A, Scholz R, Brüss V, Waldöfner N, Ricke J, Feussner A, Hildebrandt B, Rau B, Wust P. Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia. Med Phys 2004, 31:1444-1451.
3. Jordan A, Maier-Hauff K. Magnetic nanoparticles for intracranial thermotherapy. J Nanosci Nanotechnol 2007, 7:4604-4606.
4. Lipinski JK. Some observations on early diagnostic radiology in Canada. Can Med Assoc J 1983, 129: 766-768.
5. Peters TM. Image-guided surgery: from X-rays to virtual reality. Comput Methods Biomech Biomed Eng 2000, 4:27-57.
6. Barnett GH, McKenzie RL, Ramos L, Pamer J. Nonvolumetric sterotaxy-assisted craniotomy: results in 50 consecutive cases. Stereotact Funct Neurosurg 1993, 61:80-95.
7. Wirtz CR, Albert FK, Schwaderer M, Heuer C, Staubert A, Tronnier VM, Knauth M, Kunze S. The benefit of neuronavigation for neurosurgery analyzed by its impact on glioblastoma surgery. Neurol Res 2000, 22:354-360.
8. Hill DL, Maurer CR Jr, Maciunas RJ, Barwise JA, Fitzpatrick JM, Wang MY. Measurement of intraoperative brain surface deformation under a craniotomy. Neurosurgery 1998, 43:514-526.
9. Siomin V, Barnett G. Intraoperative imaging in glioblastoma resection. Cancer J 2003, 9:113-125.
10. Cash DM, Miga MI, Glasgow SC, Dawant BM, Clements LW, Cao Z, Galloway RL, Chapman WC. Concepts and preliminary data toward the realization of image-guided liver surgery. J Gastrointest Surg 2007, 11:844-859.
11. Kalfas IH, Kormos DW, Murphy MA, McKenzie RL, Barnett GH, Bell GR, Steiner CP, Trimble MB, Weisenberger JP. Application of frameless stereotaxy to pedicle screw fixation of the spine. J Neurosurg 1995, 83:641-647.
12. Rosenberger RE, Fink C, Quirbach S, Attal R, Tecklenburg K, Hoser C. The immediate effect of navigation on implant accuracy in primary mini-invasive unicompartmental knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2008, 16:1133-1140):(Epub ahead of print; September 20, 2008).
13. Smith TL, Stewart MG, Orlandi RR, Setzen M, Lanza DC. Indications for image-guided sinus surgery: the current evidence. Am J Rhinol 2007, 21:80-83.
14. Barnett GH, McKenzie RL, Ramos L, Palmer J. Nonvolumetric stereotaxy-assisted craniotomy: results in 50 consecutive cases. Stereotact Funct Neurosurg 1993, 61:80-95.
15. Barnett GH, Kormos D, Steiner C. Weisenberger: use of a sonic digitizing arm for frameless stereotaxy. Neurosurgery 1993, 33:674-678.
16. Comeau RM, Sadikot AF, Fenster A, Peters TM. Intraoperative ultrasound for guidance and tissue shift correction in image-guided neurosurgery. Med Phys 2000, 27:787-800.
17. Regelsberger J, Lohmann F, Helmke K, Westphal M. Ultrasound-guided surgery of deep seated brain lesions. Eur J Ultrasound 2000, 12:115-121.
18. LeRoux PD, Winter TC, Berger MS, Mack LA, Wang K, Elliott JP. A comparison between preoperative magnetic resonance and intraoperative ultrasound tumor volumes and margins. J Clin Ultrasound 1994, 22:29-36.
19. Nabavi A, Black PM, Gering DT, Westin CF, Mehta V, Pergolizzi RS Jr, Ferrant M, Warfield SK, Hata N, Schwartz RB, et al. Serial intraoperative magnetic resonance imaging of brain shift. Neurosurgery 2001, 48:787-797.
20. Schulder M, Liang D, Carmel PW. Cranial surgery navigation aided by a compact intraoperative magnetic resonance imager. J Neurosurg 2001, 94:936-945.
21. Black PM, Alexander E 3rd, Martin C, Moriarty T, Nabavi A, Wong TZ, Schwartz RB, Jolesz F. Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 1999, 45:423-431.
22. Hadani M, Spiegelman R, Feldman Z, Berkenstadt H, Ram Z. Novel, compact, intraoperative magnetic resonance imaging-guided system for conventional neurosurgical operating rooms. Neurosurgery 2001, 48:799-807.
23. Bohinski RJ, Kokkino AK, Warnick RE, Gaskill-Shipley MF, Kormos DW, Lukin RR, Tew JM Jr. Glioma resection in a shared-resource magnetic resonance operating room after optimal image-guided frameless stereotactic resection. Neurosurgery 2001, 48:731-742.
24. Knauth M, Aras N, Wirtz CR, Dorfler A, Engelhorn T, Sartor K. Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR Am J Neuroradiol 1999, 20:1547-1553.
25. Selverstone B, Sweet WH, Robinson CV. The clinical use of radioactive phosphorus in the surgery of brain tumors. Ann Surg 1949, 130:643-651.
26. Povoski SP, Neff RL, Mojzisik CM, O'Malley DM, Hinkle GH, Hall NC, Murrey DA Jr, Knopp MV, Martin EW Jr. A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol 2009, 7:11.
27. Somasundaram SK, Chicken DW, Keshtgar MR. Detection of the sentinel lymph node in breast cancer. Br Med Bull 2007, 84:117-131.
28. Mariani G, Gipponi M, Moresco L, Villa G, Bartolomei M, Mazzarol G, Bagnara MC, Romanini A, Cafiero F, Paganelli G, et al. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med 2002, Jun; 43:811-827.
29. Georgakoudi I, Jacobson BC, Muller MJ, Sheets E, Badizadegan K, Carr-Locke DL, Crum CP, Boone CW, Dasari RR, Van Dam J, et al. NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes. Cancer Res 2002, 62:682-687.
30. Ramanujam N, Mitchell MF, Mahadevan-Jansen A, Thomsen SL, Staerkel G, Malpica A, Wright T, Atkinson N, Richards-Kortum R. Cervical precancer detection using a multivariate statistical algorithm based on laser-induced fluorescence spectra at multiple excitation wavelengths. Photochem Photobiol 1996, 64:720-735.
31. Croce AC, Fiorani S, Locatelli D, Nano R, Ceoni M, Tancioni F, Giombelli E, Benericetti E, Bottiroli G. Diagnostic potential of autofluorescence for an assisted intraoperative delineation of glioblastoma resection margins. Photochem Photobiol 2003, 77:309-318.
32. Toms SA, Konrad PE, Lin WC, Weil RJ. Neuro-oncological applications of optical spectroscopy. Technol Cancer Res Treat 2006, 5:231-238.
33. Toms SA, Lin WC, Weil RJ, Johnson MD, Jansen ED, Mahadevan-Jansen A. Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity. Neurosurgery 2005, 57(4 suppl):382-391.
34. Lin WC, Mahadevan-Jansen A, Johnson MD, Weil RJ, Toms SA. In vivo optical spectroscopy detects radiation damage in brain tissue. Neurosurgery 2005, 57:518-525.
35. Shinoda J, Yano H, Yoshimura S, Okumura A, Kaku Y, Iwama T, Sakai N. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium: technical note. J Neurosurg 2003, 99:597-603.
36. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000, 93: 1003-1013.
37. Newman EA, Newman LA. Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin North Am 2007, 87:353-364.
38. Schaar JA, Mastik F, Regar E, den Uil CA, Gijsen FJ, Wentzel JJ, Serruys PW, van der Stehen AF. Current diagnostic modalities for vulnerable plaque detection. Curr Pharm Des 2007, 13:995-1001.
39. Perelman LT. Optical diagnostic technology based on light scattering spectroscopy for early cancer detection. Expert Rev Med Devices 2006, 3:787-803.
40. Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, Yang L, Young AN, Wang MD, Nie S. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 2008, Jan; 26:83-90.
41. Haisch C. Quantitative analysis in medicine using photoacoustic tomography. Anal Bioanal Chem 2009, 393:473-479(Epub ahead of print; November 5, 2008).
42. Cai W, Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small 2007, 3:1840-1854.
43. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science 1998, 281:2013-2016.
44. Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998, 281:2016-2018.
45. Balasubramanian K, Burghard M. Chemically functionalized carbon nanotubes. Small 2005, 1:180-192.
46. Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv Drug Deliv Rev 2006, 58:1460-1470(Epub ahead of print; September 30, 2006).
47. Hirsch LR, Gobin AM, Lowery AR, Tam F, Drezek RA, Halas NJ, West JL. Metal nanoshells. Ann Biomed Eng 2006, 34:15-22(Epub ahead of print; Mar 10, 2006).
48. Thorek DL, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006, 34:23-38(Epub ahead of print; February 16, 2006).
49. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5:161-171.
50. Grodzinski P, Silver M, Molnar LK. Nanotechnology for cancer diagnostics: promises and challenges. Expert Rev Mol Diagn 2006, 6:307-318.
51. Michalet X, Pinaud FF, Bentolilia LA, Tsay JM, Doose S, Li JJ, Sundaresan J, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544.
52. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005, 16:63-72.
53. Vassallo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA. AMI-227-enhanced MR lymphangography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 1994, 193:501-506.
54. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 2004, 15:79-86.
55. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170(Epub ahead of print; September 23, 2007).
56. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006, 114: 165-172.
57. Fischer HC, Liu L, Pang KS, Chan WCW. Pharmacokinetics of nanoscale quantum dots: In vivo distribution, sequestration, and clearance in the rat. Adv Funct Mater 2006, 16:1299-1305.
58. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298:1759-1762.
59. Rieger S, Kulkarni RP, Darcy D, Fraser SE, Köster RW. Quantum dots are powerful multipurpose vital labeling agents in zebrafish embryos. Dev Dyn 2005, 234:670-681.
60. Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, Webb WW. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 2003, 300:1434-1436.
61. Soltesz EG, Kim S, Laurence RG, DeGrand AM, Parungo CP, Dor DM, Cohn LH, Bawendi MG, Frangioni JV, Mihaljevic T. Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann Thorac Surg 2005, 79:269-277.
62. Voura EB, Jaiswal JK, Mattoussi H, Simon SM. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med 2004, 10:993-998.
63. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, Ge N, Peale F, Bruchez MP. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003, 21:41-46.
64. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 8:969-976.
65. Cai W, Chen K, Li ZB, Gambhir SS, Chen X. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med 2007, 48:1862-1870(Epub ahead of print; October 17, 2007).
66. Jackson H, Kuhhamad O, Daneshvar D, Nelms J, Popescu A, Vogelbaum MA, Bruchez M, Toms SA. Quantum dots are phagocytized by macrophages and co-localize with experimental gliomas. Neurosurgery 2007, 60:524-530.
67. Damishear H, Nelms J, Muhammed O, Jackson H, Tkach J, Davros W, Peterson T, Vogelbaum MA, Bruchez M, Toms SA. Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots'. Nanomedicine 2008, 3:21-29.
68. King-Heiden TC, Wiecinski PN, Mangham AN, Metz KM, Nesbit D, Pedersen JA, Hamers RJ, Heideman W, Peterson RE. Quantum dot nanotoxicity assessment using the zebrafish embryo. Environ Sci Technol 2009, 43:1605-1611.
69. Wang L, Nagesha DK, Selvarasah S, Dokmeci MR, Carrier RL. Toxicity of CdSe nanoparticles in Caco-2 cell cultures. J Nanobiotechnol 2008, 6:11.
70. Kirchner C, Liedl T, Kudera S, Pellegrino T, Muñoz Javier A, Gaub HE, Stölzle S, Fertig N, Parak WJ. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett 2005, 5:331-338.
71. Neuwelt EA, Hamilton BE, Varallyay CG, Rooney WR, Edelman RD, Jacobs PM, Watnick SG. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int 2009, 75:465-474(Epub ahead of print; October 8, 2008).
72. Fleige G, Nolte C, Synowitz M, Seeberger F, Kettenmann H, Zimmer C. Magnetic labeling of activated microglia in experimental glioma. Neoplasia 2001, 3:489-499.
73. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 2003, 63:8122-8125.
74. Zhang Y, Kohler N, Zhang M. Surface modifications of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002, 23:1553-1561.
75. Corot C, Petry KG, Trivedi R, Saleh A, Jonkmanns C, Le Bas JF, Blezer E, Rausch M, Brochet B, Foster-Gareau P, et al. Macrophage imaging in the central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 2004, 39:619-625.
76. Dupas B, Berreur M, Rohanizadeh R, Bonnemain B, Meflah K, Prada G. Electron microscopy study of intrahepatic ultrasmall superparamagnetic iron oxide kinetics in the rat. Relationship with magnetic resonance imaging. Biol Cell 1999, 91:195-208.
77. Yang L, Mao H, Cao Z, Wang YA, Peng X, Wang X, Sajja HK, Wang L, Duan H, Ni C, et al. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology 2009, 136:1514-25.e2(Epub ahead of print; January 14, 2009).
78. Hauck TS, Ghazani AA, Chan WC. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 2008, 4:153-159.
79. Hirsch LR, Jackson JB, Lee A, Halas NJ, West JL. A whole blood immunoassay using gold nanoshells. Anal Chem 2003, 75:2377-2381.
80. Kneipp J, Kneipp H, Kneipp K. SERS-a single-molecule and nanoscale tool for bioanalytics. Chem Soc Rev 2008, 37:1052-1060(Epub ahead of print; March 20, 2008).
81. Oh SJ, Kang J, Maeng I, Suh JS, Huh YM, Haam S, Son JH. Nanoparticle-enabled terahertz imaging for cancer diagnosis. Opt Expr 2009, 17:3469-3475.
82. Park J, Estrada A, Sharp K, Sang K, Schwartz JA, Smith DK, Coleman C, Payne JD, Korgel BA, Dunn AK, et al. Two-photon-induced photoluminescence imaging of tumors using near-infrared excited gold nanoshells. Opt Expr 2008, 16:1590-1599.
83. Averitt R, Wescott S, Halas NJ. Linear optical properties of gold nanoshells. Opt Soc Am B 1999, 6:1824-1832.
84. Oldenburg S, Averitt RD, Westcott S, Halas NJ. Nanoengineering of optical resonances. Chem Phys Lett 1998, 288:243-247.
85. Oldenburg SJ, Jackson JB, Westcott SL, Halas NJ. Infrared extinction properties of gold nanoshells. Appl Phys Lett 1999, 75:2897-2899.
86. Loo C, Lowery A, Halas N, West J, Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 2005, 5:709-711.
87. Loo C, Lin A, Hirsch L, Lee MH, Barton J, Halas N, West J, Drezek R. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat 2004, 3:33-40.
88. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 2003, 100:13549-13554(Epub ahead of print; November 3, 2003).
89. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 2004, 209:171-176.
90. Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett 2007, 7:1929-1934(Epub ahead of print; June 6, 2007).
91. Keren S, Zavaleta C, Cheng Z, de la Zerda A, Gheysens O, Gambhir SS. Noninvasive molecular imaging of small living subjects using Raman spectroscopy. Proc Natl Acad Sci USA 2008, 105: 5844-5849.
92. Wang Y, Xie X, Wang X, Ku G, Gill KL, O'Neal DP, Stoica G, Wang LV. Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain. Nano Lett 2004, 4:1689-1692.
93. Li ML, Wang JC, Schwartz JA, Gill-Sharp KL, Stoica G, Wang LV. In-vivo photoacoustic microscopy of nanoshell extravasation from solid tumor vasculature. J Biomed Opt 2009, 14:010507.
94. Song KH, Kim C, Cobley CM, Xia Y, Wang LV. Near-infrared gold nanocages as a new class of tracers for photoacoustic sentinel lymph node mapping on a rat model. Nano Lett 2009, 9:183-188.
95. Lee CC, MacKay JA, Fréchet JM, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol 2005, 23:1517-1526.
96. Svenson S, Tomalia DA. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 2005, 57:2106-2129(Epub ahead of print; November 21, 2005).
97. Tomalia DA, Reyna LA, Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 2007, 35:61-67.
98. Dufès C, Uchegbu IF, Schätzlein AG. Dendrimers in gene delivery. Adv Drug Deliv Rev 2005, 57:2177-2202(Epub ahead of print; November 28, 2005).
99. Pan B, Cui D, Sheng Y, Ozkan C, Gao F, He R, Li Q, Xu P, Huang T. Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res 2007, 67:8156-8163.
100. Manunta M, Tan PH, Sagoo P, Kashefi K, George AJ. Gene delivery by dendrimers operates via a cholesterol dependent pathway. Nucleic Acids Res 2004, 32:2730-2739.
101. Wada K, Arima H, Tsutsumi T, Chihara Y, Hattori K, Hirayama F, Uekama K. Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates. J Control Release 2005, 104:397-413.
102. Wu G, Barth RF, Yang W, Kawabata S, Zhang L, Green-Church K. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates. Mol Cancer Ther 2006, 5:52-59.
103. Majoros IJ, Myc A, Thomas T, Mehta CB, Baker JR Jr. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules 2006, 7:572-579.
104. Chandrasekar D, Sistla R, Ahmad FJ, Khar RK, Diwan PV. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. Biomaterials 2007, 28:504-512(Epub ahead of print; September 22, 2006).
105. Lai PS, Lou PJ, Peng CL, Pai CL, Yen WN, Huang MY, Young TH, Shieh MJ. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. J Control Release 2007, 122:39-46.
106. Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med 1994, 31:1-8.
107. Kobayashi H, Brechbiel MW. Dendrimer-based macromolecular MRI contrast agents: characteristics and application. Mol Imaging 2003, 2:1-10.
108. Kobayashi H, Brechbiel MW. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 2005, 57:2271-2286(Epub ahead of print; November 10, 2005).
109. Wiener EC, Konda S, Shadron A, Brechbiel M, Gansow O. Targeting dendrimers-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Invest Radiol 1997, 32:748-754.
110. Fu Y, Nitecki DE, Maltby D, Simon GH, Berejnoi K, Raatschen HJ, Yeh BM, Shames DM, Brasch RC. Dendritic iodinated contrast agents with PEG-cores for CT imaging: synthesis and preliminary characterization. Bioconjug Chem 2006, 17:1043-1056.
111. Xu H, Regino CA, Koyama Y, Hama Y, Gunn AJ, Bernardo M, Kobayashi H, Choyke PL, Brechbiel MW. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug Chem 2007, 18:1474-1482(Epub ahead of print; August 21, 2007).
112. Koyama Y, Talanov VS, Bernardo M, Hama Y, Regino CA, Brechbiel MW, Choyke PL, Kobayashi H. A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging 2007, 25:866-871.
113. Kobayashi H, Koyama Y, Barrett T, Hama Y, Regino CA, Shin IS, Jang BS, Le N, Paik CH, Choyke PL, et al. Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. ACS Nano 2007, 1:258-264.
114. Wang HF. Biodistribution of carbon single-wall carbon nanotubes in mice. J Nanosci Nanotechnol 2004, 4:1019-1024.
115. Singh R. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 2006, 103:3357-3362.
116. Liu Z, Cai W, He L, Nakayama N, Chen K, Sun X, Chen X, Dai H. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2007, 2:47-52(Epub ahead of print; December 17, 2006).
117. De la Zerda A, Zavaleta C, Keren S, Vaithilingam S, Bodapati S, Liu Z, Levi J, Smith BR, Ma TJ, Oralkan O, et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 2008, 3:557-562(Epub ahead of print; August 17, 2008).
118. Gregoriadis G, Neerunjun T. Homing of liposomes to target cells. Biochem Biophys Res Commun 1975, 65:537-544.
119. Keren S, Zavaleta C, Cheng Z, de la Zerda A, Gheysens O, Gambhir SS. Noninvasive molecular imaging of small living subjects using Raman spectroscopy. Proc Natl Acad Sci USA 2008, 105:5844-5849(Epub ahead of print; March 31, 2008).
120. Gregoriadis G. Targeting of drugs: implications in medicine. Lancet 1981, 318:241-246.
121. Gregoriadis G. The carrier potential of liposomes in biology and medicine. N Engl J Med 1976, 704:110.
122. Gregoriadis G. Drug entrapment in liposomes. FEBS Lett 1973, 36:292-296.
123. Torchilin VP. Liposomes as delivery agents for medical imaging. Mol Med Today 1996, 2:242-249.
124. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
125. Dams ET, Oyen WJ, Boerman OC, Storm G, Laverman P, Kok PJ, Buijs WC, Bakker H, van der Meer JW, Corstens FH. 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med 2000, 41:622-630.
126. Ghaghada KB, Bockhorst KH, Mukundan S Jr, Annapragada AV, Narayana PA. High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent. AJNR Am J Neuroradiol 2007, 28:48-53.
127. Mulder WJ, Strijkers GJ, Habets JW, Bleeker EJ, van der Schaft DW, Storm G, Koning GA, Griffioen AW, Nicolay K. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 2005, 19:2008-2010(Epub ahead of print; October 4, 2005).
128. Alkan-Onyuksel H, Demos SM, Lanza GM, Vonesh MJ, Klegerman ME, Kane BJ, Kuszak J, McPherson DD. Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci 1996, 85:486-490.
129. Demos SM, Alkan-Onyuksel H, Kane BJ, Ramani K, Nagaraj A, Greene R, Klegerman M, McPherson DD. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol 1999, 33:867-875.
130. Hamilton A, Huang SL, Warnick D, Stein A, Rabbat M, Madhav T, Kane B, Nagaraj A, Klegerman M, MacDonald R, et al. Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model. Circulation 2002, 105:2772-2778.
131. Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, Sharkey AM, Miller JG, Gaffney PJ, Wickline SA. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996, 94:3334-3340.
132. Lanza GM, Trousil RL, Wallace KD, Rose JH, Hall CS, Scott MJ, Miller JG, Eisenberg PR, Gaffney PJ, Wickline SA. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am 1998, 104: 3665-3672.
133. Lanza GM, Wallace KD, Fischer SE, Christy DH, Scott MJ, Trousil RL, Cacheris WP, Miller JG, Gaffney PJ, Wickline SA. High-frequency ultrasonic detection of thrombi with a targeted contrast system. Ultrasound Med Biol 1997, 23:863-870.
134. Lanza G, Lorenz C, Fischer S, Scott M, Cacheris W, Kaufman R, Gaffney P, Wickline S. Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. Acad Radiol 1998, 5(suppl 1):s173-s176.
135. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001, 104: 1280-1285.
136. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003, 108:2270-2274(Epub ahead of print; October 13, 2003).
137. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79:1157-1164.
138. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Schwartz SM. Angiogenesis in human coronary atherosclerotic plaque. Am J Pathol 1994, 145:883-894.
139. Mulder WJ, Castermans K, van Beijnum JR, Oude Egbrink MG, Chin PT, Fayad ZA, Löwik CW, Kaijzel EL, Que I, Storm G, et al. Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots. Angiogenesis 2009, 12:17-24.
140. Smith BR, Cheng Z, De A, Koh AL, Sinclair R, Gambhir SS. Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. Nano Lett 2008, 8:2599-2606.
141. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival'. J Neurosurg 2001, 95:190-198.
142. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 2008, 63:700-707.
143. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 2008, 26:1338-1345.